Neurocognitive functioning predicts frailty index in HIV
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To evaluate the association between a frailty index (i.e., scale of accumulated deficits) and neurocognitive functioning among persons living with HIV/AIDS (PLWHA).
Methods Observational, cross-sectional data were gathered from the University of California, San Diego, HIV Neurobehavioral Research Program from 2002 to 2016. Eight hundred eleven PLWHA aged 18 to 79 years completed comprehensive physical, neuropsychological, and neuromedical evaluations. The frailty index was composed of 26 general and HIV-specific health maintenance measures, and reflects the proportion of accumulated deficits from 0 (no deficits) to 1 (all 26 deficits). Multiple linear regression was used to examine the association between continuous frailty index scores and neurocognitive functioning.
Results Participants had a mean age of 44.6 years (11.2), and were mostly male (86.9%) and white (60.2%) with a mean frailty index of 0.26 (0.11). Over the study period, prevalence of HIV-related components (e.g., low CD4) decreased, while non-HIV comorbidities (e.g., diabetes) increased. There were no changes in the frailty index by study year. Higher frailty index was associated with worse global neurocognitive functioning, even after adjusting for covariates (age, employment, and premorbid intellectual functioning; b = −0.007; 95% confidence interval [CI] = −0.0112 to −0.003; p < 0.001). The cognitive domains of verbal fluency (b = −0.004; 95% CI = −0.006 to −0.002), executive functioning (b = −0.004; 95% CI = −0.006 to −0.002), processing speed (b = −0.005; 95% CI = −0.007 to −0.003), and motor skills (b = −0.006; 95% CI = −0.007 to −0.005) also significantly predicted worse frailty index score (p values <0.001).
Conclusion A frailty index can standardize how clinicians identify PLWHA who may be at higher risk of neurocognitive impairment.
Glossary
- cART=
- combination antiretroviral therapy;
- CI=
- confidence interval;
- DSM-IV=
- Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition);
- HAND=
- HIV-associated neurocognitive disorders;
- HNRP=
- HIV Neurobehavioral Research Program;
- IADL=
- instrumental activities of daily living;
- NNRTI=
- nonnucleoside reverse transcriptase inhibitor;
- NP=
- neuropsychological;
- NRTI=
- nucleoside reverse transcriptase inhibitor;
- PI=
- protease inhibitor;
- PLWHA=
- persons living with HIV/AIDS;
- SS=
- scaled score;
- WRAT=
- Wide Range Achievement Test
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received September 22, 2017.
- Accepted in final form April 5, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David Beversdorf and Dr. Ryan Townley
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R. Franklin, Jr, Reena Deutsch et al.Neurology, May 09, 2014 -
Articles
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive personsE.J. Wright, B. Grund, K. Robertson et al.Neurology, August 11, 2010 -
Article
Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected peopleDavid B. Clifford, Florin Vaida, Yu-Ting Kao et al.Neurology, December 10, 2014 -
Articles
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patientsN. Ciccarelli, M. Fabbiani, S. Di Giambenedetto et al.Neurology, April 18, 2011